Dean Gaalaas has joined GeneDx as COO. Gaalaas was previously CEO of Edge Biosystems, but made the move to GeneDx as part of an acquisition by GeneDx's parent company BioReference Laboratories of EdgeBio's sequencing services business, Edge BioServ. Gaalaas joined EdgeBio in 1999, becoming its CEO in 2004.
Pathway Genomics has named Karl Odquist as executive director of managed care. He will be responsible for managed care contracting, reimbursement, government affairs, and clinical evidence generation for the company’s diagnostic services.
Odquist has served in various roles at pharmaceutical and diagnostic companies, most recently at Prometheus Laboratories.